Pharmafile Logo
Pharmafocus logo
Advanced Search
Pfizer sign

Experts predict pharma sector to remain strong in 2016

December 21, 2015
Sales and Marketing marketing, pharma, profits, sales

The year 2016 is set to see continued growth in research and development productivity, with significant new drug launches and …

News
Ionis logo

ISIS Pharma changes name to Ionis to avoid ‘distracting’ militant association

December 21, 2015
Sales and Marketing Ionis, Isis Pharmaceuticals, branding, marketing, rebrand

After months of discussion, ISIS Pharmaceuticals has changed its name to Ionis to free itself from the fear of confusion …

News
580x381_merck_opens_its_office_in_nigeria_3_tcm2432_145041

Merck on the march in Africa

December 21, 2015
Sales and Marketing Africa, Merck, marketing, sales, strategy

When Merck unveiled its Africa 2020 strategy in November, there was no shortage of ambition.The company announced plans to expand …

Feature
EU flag

Three AstraZeneca drugs recommended by EMA committee

December 21, 2015
Sales and Marketing AstraZeneca, Brilique, CHMP, EMA, Portrazza, Tagrisoo, lesinurad, lilly

The EMA’s Committee for Medicinal Products for Human Use (CHMP) has recommended several new drugs in its latest meeting, including …

News
shkreli_thumb

Martin Shkreli resigns from Turing

December 21, 2015
Sales and Marketing Martin Shkreli, Shkreli, Turing Pharmaceuticals

Following his arrest on securities fraud charges, Martin Shkreli has resigned as chief executive of Turing and been replaced by …

Appointment
paris_alternate_high-res_web

Ariad names EMD Serono’s Paris Panayiotopoulos as new president and chief exec

December 21, 2015
Sales and Marketing Ariad, Ariad Pharmaceuticals, EMD Serono, Paris Panayiotopoulos, harvey Berger

The board of directors at Ariad Pharmaceuticals has appointed Paris Panayiotopoulos as president and chief executive from 1 January 2016. …

Appointment
Gilead sign

Gilead steps in to rescue Galapagos RA drug

December 18, 2015
Sales and Marketing AbbVie, Gilead, Gilead Sciences, filgotinib, inflammation, inflammatory diseases, rheumatoid arthritis

Gilead Sciences is to pay $725million for the rights to filgotinib, a JAK1-selective inhibitor for rheumatoid arthritis and other inflammatory …

News
Imlygic

European approval for Amgen cancer drug Imlygic

December 18, 2015
Sales and Marketing Amgen, European Commission, Imlygic, melanoma, skin cancer, t-vec, talimogene laherparepvec

The European Commission has approved the use of Amgen’s Imlygic for adults with advanced melanoma, making it the first drug …

News
shkreli_youtube_screenshot

Karma may have caught up with Martin Shkreli, but America’s drug pricing problem isn’t about one man

December 18, 2015
Manufacturing and Production, Sales and Marketing Daraprim, Martin Shkreli, Turing Pharmaceuticals

As so often occurs in situations of this kind, Twitter reacted with a significant amount of glee and schadenfreude to …

Feature
ceo_arnaud_lallouette

Servier UK appoints new chief executive

December 18, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Arnaud Lallouette, Mike Sumpter, Servier

Dr Arnaud Lallouette has been appointed chief executive of Servier Laboratories, the UK subsidiary of the French-based pharma firm, after …

Appointment
tim-walbert

Horizon chief exec Walbert to head up US biotech trade body

December 18, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Illinois Biotechnology Industry Organisation, Timothy Walbert, iBio, illinois

Timothy Walbert, the chairman, president and chief executive of Horizon Pharma, has been elected as chairman of the board of …

Appointment
landing-hero-images1

ViiV Healthcare to acquire Bristol-Myers Squibb’s HIV pipeline drugs

December 18, 2015
Medical Communications, Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb, HIV, ViiV, ViiV Healthcare

Specialist HIV company ViiV Healthcare has agreed deals worth up to $1.46 billion to purchase Bristol-Myers Squibb’s late stage HIV …

News
astellas_main_web_2_0

Astellas investigated for ‘misleading’ PMCPA during ABPI code complaint

December 18, 2015
Medical Communications ABPI Code, Astellas, Astellas Pharma Europe, PMCPA, Prescription Medicines Code of Practice Authority

The Prescription Medicines Code of Practice Authority is investigating Astellas for deliberately providing an ‘incomplete and misleading’ response to a …

News

Prime Medical Group expands senior editorial team

December 17, 2015
Medical Communications Prime Medical Group

The Prime Medical Group has announced the appointment of Valerie Moss PhD to the position of editorial & scientific executive …

Appointment
Alliance Pharma logo

Alliance Pharma buys Sinclair’s healthcare products business for £132m

December 17, 2015
Manufacturing and Production, Sales and Marketing Alliance Pharma, Sinclair IS Pharma, acquisitions, dermatology merger

Alliance has completed a £132 million purchase of Sinclair IS Pharma’s non-aesthetics healthcare business as it moves to strengthen its …

News
FDA sign

FDA approves Lilly/Boehringer Lantus biosimilar

December 17, 2015
Medical Communications, Sales and Marketing Basaglar, Boehringer Ingelheim, Eli Lilly, Lantus, Sanofi, abasaglar, biosimilar, diabetes, insulin, lilly

The FDA has approved Eli Lilly and Boehringer Ingelheim’s long-acting insulin Basaglar (insulin glargine injection – a biosimilar to rival Sanofi’s …

News
ABPI code

Pharma company accused of ‘bribing’ prescribers slammed by PMCPA

December 17, 2015
Medical Communications ABPI Code, Daily Telegraph, PMCPA, Prescription Medicines Code of Practice Authority, Stirling Anglian

Stirling Anglian, the company at the centre of media criticism for arranging meetings at lavish hotels in an attempt to …

News
Shkreli KaloBios

Turing chief exec Martin Shkreli arrested

December 17, 2015
Medical Communications, Sales and Marketing Daraprim, FBI, Martin Shkreli, Shkreli, turing

Turing chief executive Martin Shkreli has been arrested on a charge of securities fraud relating to a company he founded, …

News
National Institutes of Health building

Clinical trials increasingly funded by pharma industry

December 17, 2015
Research and Development JAMA, Journal of the American Medical Association, NIH, National Institutes of Health, clinical trials, clinicaltrials.gov, pharma, research

The number of clinical trials funded by pharma has risen significantly since 2006, while the number funded by the US …

News

AstraZeneca to buy majority share in Acerta Pharma

December 17, 2015
Sales and Marketing Acerta Pharma, AstraZeneca, acalabrutinib, acquisitions, mergers

Following several days of speculation, AstraZeneca has announced that it has agreed a deal to buy Acerta Pharma, a developer …

News
The Gateway to Local Adoption Series

Latest content

Japanese pharma outsources earlier as peptide development challenges grow

April 29, 2026

Study suggests phospholipid therapy may impact fatty liver disease outcomes

April 29, 2026

FDA signals support for development of psychedelic therapies in mental healthmental health

April 28, 2026

New web series explores path from ophthalmic research to patient access

April 28, 2026

EMA backs plozasiran for rare lipid disorder with high pancreatitis risk

April 27, 2026